A randomised control trial to determine if the review of non-mydriatic retinal images can contribute to a reduction in glycosylated hemoglobin in patients with poor control of their blood sugar diabetic retinopathy

Not Applicable

Completed

• Conditions: Diabetic Retinopathy; Eye - Diseases / disorders of the eye; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12609000362291
• Lead Sponsor: American University of Beirut Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-05-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

patients with type 1 or type 2 diabetes mellitus, as defined by the expert committee on the diagnosis and classification of Diabetes Mellitus, patients with documented poor glycemic control as reflected in a HbA1C> or = 8.0% within 1 month of baseline, patients with recently recognized clinical changes of DR in their medical record (Early Treatment Diabetic Retinopathy Study scores of 20 and above), and ability to obtain nonmydriatic retinal images

Exclusion Criteria

gestational diabetes mellitus, media clarity inadequate for nonmydriatic retinal imaging, poor visual acuity (Early Treatment Diabetic Retinopathy Study Visual Acuity < 20/100) and patients using pupillary constricting agents as a treatment modality for glaucoma.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood analysis of HbA1C at study entry and at 3 months follow up level[Baseline and at 3 months following treatment]

Secondary Outcome Measures

Name	Time	Method
none[n/a]